Proven analytical capabilities for ADC manufacturing
We are recognized for our industry-leading expertise. Our clients get access to a global network of development and manufacturing sites in North America, Europe and Asia. A dedicated team will support you with new method development or optimization, method transfers and qualification/validation:
- Cleaning (swab/rinse by TOC; conductivity)
- Complete analytical development packages
- DS/DP release testing and stability testing
And much more.
Complete access to a broad range of analytical techniques
For your ADC drug substance and drug product release and stability testing stages, we provide you with access to our team, and a range of analytical approaches, including:
- HPLC (e.g. SEC, HIC, RP)
- CE (e.g. CE-SDS)
- icIEF (charge heterogeneity)
- LC-MS
- UV (e.g. for protein concentration)
- ELISA
- Cell-based potency assays, including establishment of cell banks
And much more.
Our locations
Locations where this service is provided
Visp, Switzerland
Founded in 1897, Lonza today is a dedicated strategic manufacturing partner to the healthcare industry, working with customers in the pharma, biotech and nutrition markets. Visp remains our largest site in a global network of more than 30 sites and one of the most significant for research and development and manufacturing.
Our Visp site is a complex of industry-leading facilities specializing in the development and manufacture of products for pharmaceutical applications including mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to our pioneering Ibex® Solutions services offering. Ibex® Solutions enables customers to accelerate their path throughout the complete biopharmaceutical lifecycle - from preclinical to commercial stages, from drug substance to drug product, all in one location.